When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

Wegovy and other injectable weight-loss medications have soared in popularity in the past two years. Supply issues and spotty insurance coverage have driven some patients to seek out compounded ...

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally ...

CARRY RISK. WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED SEMAGLUTIDE AS PART OF ITS HOLISTIC WEIGHT MANAGEMENT PROGRAM. WE ARE AT A CROSSROADS HERE WHERE WE HAVE MILLIONS OF ...

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

In these cases, compounded drugs are filling a specific need. While many GLP-1s were on the FDA’s shortage list, as of earlier this year, the FDA has removed them, meaning that the compounding of ...

The repeat problems at Houston-based Empower Pharmacy include inadequate quality testing and a failure to clean equipment.